Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Eli Lilly's Foundayo Tops Oral Semaglutide On Key Measures In Type 2 Diabetes Trial

    1 day ago

    Over 52 weeks, the Achieve-3 study compared two doses of Foundayo with approved oral semaglutide doses in 1,698 people with type 2 diabetes who were not adequately controlled on metformin.
    Click here to Read More
    Previous Article
    Textile PLI Scheme 3.0: 96 Firms Selected With Investment Commitment Of Nearly Rs 13,000 Crore
    Next Article
    Airtel Rebrands Priority Postpaid As Fast Lane

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment